Inguinal Hernia
Conditions
Keywords
Inguinal Hernia, Laparoscopic Inguinal Hernia Repair, Aspirin
Brief summary
This study aims to assess the need to stop Aspirin before elective laparoscopic inguinal hernia repair. It will consist of 2 arms: patients who continue to take Aspirin perioperatively and patients who stop Aspirin 5-7 days before the surgery.
Detailed description
This study aims to assess the need to stop Aspirin before elective laparoscopic inguinal hernia repair. It will consist of 2 arms: patients who continue to take Aspirin perioperatively and patients who stop Aspirin 5-7 days before the surgery. Simple randomization will be performed and allocation is via closed envelope method. The surgeon will be blinded regarding the usage of Aspirin. The primary outcome is the incidence of post-operative hematoma formation within the first 24 hours after surgery. The secondary outcomes are the incidence of post-operative seroma formation within 24 hours, the incidence of post-operative hematoma requiring intervention (including blood transfusion, percutaneous drainage and surgical hemostasis) within 30 days, pain at regular intervals and the incidence of other post-operative complications.
Interventions
PROCEDURELaparoscopic inguinal hernia repair with perioperative Aspirin
Patients undergoing laparoscopic inguinal hernia repair will continue on Aspirin perioperatively
PROCEDURELaparoscopic inguinal hernia repair without perioperative Aspirin
Patients undergoing laparoscopic inguinal hernia repair will stop Aspirin 5-7 days before the surgery
Sponsors
National University Hospital, Singapore
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Patients with a diagnosis of inguinal hernia undergoing laparoscopic repair * Age 21-80 years * Patients taking Aspirin * BMI 18-30
Exclusion criteria
* Age \<21 and \>80years * Recurrent inguinal hernia * Coagulopathy * Patients who can't stop Aspirin * BMI \<18 and \>30
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of hematoma | 24 hours | Postoperative scrotal or groin hematoma (not including skin bruising) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of seroma | 24 hours | Postoperative scrotal or groin seroma |
| Incidence of hematoma requiring intervention | 30 days | Including blood transfusion, percutaneous drainage or surgical hemostasis |
Countries
Singapore
Contacts
Primary ContactDavide Lomanto, MD PhD
Outcome results
None listed